View in a different locale / language
United States
Chrissy Leslie, Senior Director, Corporate Sustainability, Equality Ambassador
The Eurofins network of companies continues to take meaningful actions and drive forward progress as it relates to our ESG performance and corporate social responsibility.
An exciting development that was officially finalized in early 2024 was that Eurofins signed the Science Based Target Initiative (SBTi) commitment letter, joining the growing group of companies setting ambitious science-based targets. This commitment is an expectation of many of our customers so we were eager to advance our carbon footprint reduction efforts through sustainable business practices in this manner.
Refer to the Eurofins 2023 ESG Report for a more comprehensive overview of our Corporate Sustainability approach and the actions taken across the entire Eurofins global network of companies.
The Eurofins BioPharma Product Testing business line in North America is one of the leaders within Eurofins when it comes to formal sustainability program efforts. One of the driving forces behind the continuous improvement of these initiatives has been that many of the customers we support have always advocated for sustainability efforts in their own organizations, resulting in mutual collaboration to enhance and expand our own sustainability program over the years.
Some notable accomplishments from 2023 and early 2024 include: